NASDAQ: ASBP
Aspire Biopharma Holdings Inc Stock Ownership - Who owns Aspire Biopharma Holdings?

Insider buying vs selling

Have Aspire Biopharma Holdings Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ASBP insiders and whales buy or sell their stock.

ASBP Shareholders

What type of owners hold Aspire Biopharma Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Surendra K. Ajjarapu307.83%4,317,500$35.92MInsider
Powerup Sponsor LLC204.63%2,870,000$23.88MInsider
Donald G. Fell1.43%20,000$166.40kInsider
Janstr0.00%15$124.80Institution
Jane Street Group LLC0.00%14$116.48Institution
Vanguard Capital Management LLC0.00%10$83.20Institution
Geode Capital Management LLC0.00%10$83.20Institution
Vanguard Fiduciary Trust Co0.00%10$83.20Institution
Vangrd0.00%10$83.20Institution
Vanfid0.00%10$83.20Institution

1 of 4

ASBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ASBP0.00%100.00%
KPRX0.01%99.99%Net SellingNet Selling
MBRX0.00%32.51%Net Selling
PHIO0.00%100.00%Net SellingNet Selling
INAB0.02%99.98%Net Buying

Aspire Biopharma Holdings Stock Ownership FAQ

Who owns Aspire Biopharma Holdings?

Aspire Biopharma Holdings (NASDAQ: ASBP) is owned by 0.00% institutional shareholders, 513.88% Aspire Biopharma Holdings insiders, and 0.00% retail investors. Surendra K. Ajjarapu is the largest individual Aspire Biopharma Holdings shareholder, owning 4.32M shares representing 307.83% of the company. Surendra K. Ajjarapu's Aspire Biopharma Holdings shares are currently valued at $35.92M.

If you're new to stock investing, here's how to buy Aspire Biopharma Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.